Moody's Ratings (Moody's) has completed a periodic review of the ratings of Attijariwafa bank and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 20 June 2024 in which we reassessed the appropriateness of the ratings in the context of ...
We reiterate our long-term positive view that PTTEP will post positive sales volume growth of 3% CAGR during 2023-27 on the back of better contributions from its Erawan G1/61 gas field and major projects including the world’s second-largest LNG Mozambique, as well as the SK410B project, a world-class, large-scale project in 2027. PTTEP, OR and SPRC remain our sector top picks. Maintain BUY. Target price: Bt195.00.
Feature article: A glass half-empty view of markets - The 20s harder than the last decade This month’s feature article is written by Steve Clapham, who gives his view on the outlook for markets. He sets out one side of the current debate in markets. Steve is admirably experienced to express an opinion. Steve is the founder of Behind the Balance Sheet, an investor training consultancy. He qualified as a chartered accountant before moving into investment banking as an analyst in the 1980s. In ...
KEY HIGHLIGHTS Results ENN Energy Holdings (2688 HK/BUY/HK$120.70/Target: HK$145.00) 1H22: In line; gross margin narrowed by 5.3ppt. Ping An Healthcare and Technology Company (1833 HK/BUY/HK$19.76/Target: HK$27.00) 1H22: Revenue down 25.9% yoy; making smooth progress in strategy upgrade. Shanghai Henlius Biotech (2696 HK/HOLD/HK$15.86/Target: HK$17.00) 1H22: Revenue up 103.4% yoy; raise 2022 revenue growth target to 85% yoy. Xiaomi Corp (1810 HK/BUY/HK$11.66/Target: HK$13.00) 2Q22: In line; ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.